Hemogenyx Pharma Plc (HEMO.L) New Corporate Video and Investor Webinar

Hemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases.

Hemogenyx  More Than A Covid-19 Gold Rush Play

Is pleased to announce that a new corporate video is available to view on the Company’s website and can be accessed here

 

 

In addition, the Company also announces that Dr Vladislav Sandler, Chief Executive Officer & Co-Founder of Hemogenyx Pharmaceuticals will host a live investor webinar on 20 July 2020 at 16:00 UK time at which he will answer questions about the Company’s current activities.

If you would like to register for the webinar, please follow this link:

https://us02web.zoom.us/meeting/register/tZIocuyrqj4pH9HRgZuobXLJdSDkRXUDFRDU

After registering, you will receive a confirmation email containing information about joining the meeting.

Please submit your questions in advance and not later than 17 July 2020 by emailing hemogenyx@hemogenyx.com .


Linking Shareholders and Executives :Share Talk

If anyone reads this article found it useful, helpful? Then please subscribe www.share-talk.com or follow SHARE TALK on our Twitter page for future updates.

Terms of Website Use

All information is provided on an as-is basis. Where we allow Bloggers to publish articles on our platform please note these are not our opinions or views and we have no affiliation with the companies mentioned

Share via
Copy link
Malcare WordPress Security